LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
--
--(--)
LXEO fundamentals
Lexeo Therapeutics (LXEO) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.6 (YoY +6.25%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.6
+6.25%
Report date
Aug 14, 2025
Earnings Call
9:30 AM on Aug 11, 2025
Meeting link.EPS
Actual | -0.86 | -0.64 | -0.89 | -0.78 | -0.99 | -0.6 |
Forecast | -0.6967 | -0.6914 | -0.6784 | -0.8071 | -0.7833 | -0.6794 |
Surprise | -23.44% | +7.43% | -31.19% | +3.36% | -26.39% | +11.69% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What guidance did Lexeo Therapeutics's management provide for the next earnings period?What is Lexeo Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Lexeo Therapeutics's earnings call?What does Lexeo Therapeutics do and what are its main business segments?What were the key takeaways from Lexeo Therapeutics’s earnings call?What is the market's earnings forecast for Lexeo Therapeutics next quarter?What factors drove the changes in Lexeo Therapeutics's revenue and profit?What is Lexeo Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
